Your browser doesn't support javascript.
loading
Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
Gladman, Dafna D; Mease, Philip J; Ritchlin, Christopher T; Choy, Ernest H S; Sharp, John T; Ory, Peter A; Perdok, Renee J; Sasso, Eric H.
Affiliation
  • Gladman DD; University of Toronto, and Toronto Western Hospital, Toronto, Ontario, Canada. dafna.gladman@utoronto.ca
Arthritis Rheum ; 56(2): 476-88, 2007 Feb.
Article in En | MEDLINE | ID: mdl-17265483
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2007 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2007 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos